Dog Parvo (Parvovirus): Symptoms, Treatment, and Prevention
PARVO IS LIFE-THREATENING IN UNVACCINATED DOGS
If your unvaccinated puppy or dog has bloody diarrhea, vomiting, and is lethargic and refusing food, go to a veterinary clinic immediately. Parvo can kill within 24 to 72 hours of symptom onset without treatment. Do not wait to see if symptoms improve.
This article is reviewed for clinical accuracy. Always consult your veterinarian for diagnosis and treatment.
Key Takeaways
- Canine parvovirus (CPV-2) attacks the rapidly dividing cells of the intestinal lining and bone marrow, causing hemorrhagic gastroenteritis, severe dehydration, and life-threatening sepsis; the virus is shed in enormous quantities in feces and survives in the environment for up to a year.
- Puppies between 6 weeks and 6 months old who have not completed their vaccination series are at the highest risk; breeds including Rottweiler, Doberman Pinscher, American Pit Bull Terrier, Labrador Retriever, and German Shepherd have documented higher susceptibility or more severe disease compared to other breeds.
- Survival rates with aggressive inpatient treatment (IV fluids, antibiotics, anti-nausea medications, nutritional support) reach 85 to 95 percent; survival with no treatment is less than 10 percent, and survival with only oral supportive care at home is approximately 20 to 30 percent.
- The core vaccination series (CPV component of the DA2PP or DHPP vaccine) is highly effective; puppies require a series of doses every 3 to 4 weeks from 6 to 8 weeks of age through 16 weeks, and are not considered fully protected until 2 weeks after the final puppy dose.
- Parvovirus can persist on surfaces, soil, shoes, and clothing for months to years; standard household cleaners do not inactivate it; diluted bleach (1:30 ratio, approximately 1 part bleach in 30 parts water) is required on surfaces that can tolerate it.
- There is no antiviral drug that kills parvovirus; treatment is entirely supportive, aimed at keeping the dog alive long enough for its immune system to clear the virus while preventing dehydration, secondary bacterial infection, and septic shock.
The call came at 2 a.m. A family had adopted a 10-week-old Labrador mix from a neighbor three days earlier. She had been playful the first day, a little quiet the second, and by early Tuesday morning she was vomiting repeatedly and had bloody diarrhea soaking her bedding. At the emergency clinic, the SNAP parvo test was positive within two minutes. The puppy had not received any vaccinations at the neighbor’s home. After four days in the hospital on IV fluids, antibiotics, and anti-nausea medications, she went home. Many puppies do not. Of the dogs admitted for parvovirus in the United States each year, the vast majority are unvaccinated puppies under 6 months old, and the illness kills an estimated 50,000 to 100,000 dogs annually, almost all of which could have been prevented with a vaccine that costs less than $30.
What Parvovirus Is and How It Works
Canine parvovirus type 2 (CPV-2) is a small, non-enveloped single-stranded DNA virus of the family Parvoviridae. It emerged as a new pathogen in 1978, likely having mutated from feline panleukopenia virus (FPV), and spread globally within two years, causing widespread mortality in unimmunized dog populations. The original CPV-2 strain was subsequently replaced by variant strains CPV-2a (1979), CPV-2b (1984), and CPV-2c (2000); CPV-2b and CPV-2c are currently the dominant strains in North America. Current vaccines protect against all variants.
The Virus’s Mechanism of Attack
CPV-2 requires rapidly dividing cells to replicate; it has evolved to target the body’s areas of highest cell turnover. In puppies, three primary targets bear the brunt of the infection:
- Intestinal crypt cells (crypts of Lieberkuhn): These cells at the base of the intestinal villi generate the entire intestinal lining, replacing it every 3 to 4 days. When CPV-2 destroys them, the intestinal villi collapse, causing villus atrophy. The intestinal barrier disintegrates, resulting in massive fluid and protein loss (hemorrhagic diarrhea), and allowing intestinal bacteria including Escherichia coli, Clostridium perfringens, and Campylobacter spp. to translocate directly into the bloodstream (sepsis).
- Bone marrow precursor cells (myeloid progenitors): Destruction of these cells causes severe neutropenia (dangerously low white blood cell count), which eliminates the dog’s ability to fight infection. The neutropenia typically develops 3 to 5 days after infection and coincides with the period of maximum risk from sepsis.
- Lymphoid tissue (thymus in very young puppies, Peyer’s patches): Destruction of lymphoid tissue further impairs immune function. In puppies under 8 weeks, the virus may also attack cardiac muscle cells, causing myocarditis; this form (the “cardiac form”) is now rare because most dogs have some maternal antibody protection.
The Role of Maternal Antibody Interference
Puppies receive maternal antibodies (MDA) through colostrum (the first milk) in the first 24 to 48 hours of life. These antibodies protect against CPV-2 in early puppyhood but also neutralize vaccine virus, preventing effective immunization. The problem is that MDA titers decline unpredictably between individual puppies; some puppies lose maternal protection and become susceptible as early as 6 weeks of age, while others retain protection until 12 to 14 weeks. This creates a “window of susceptibility” where maternal antibodies have fallen below protective levels but vaccine-induced immunity has not yet been established, which is why the puppy vaccine series requires multiple doses spaced 3 to 4 weeks apart.
How Parvovirus Spreads
Routes of Transmission
CPV-2 spreads by the fecal-oral route: a susceptible dog ingests the virus, most commonly by direct contact with infected feces, infected dogs, or contaminated surfaces. An infected dog begins shedding virus in feces 3 to 4 days after exposure (before symptoms appear) and continues shedding for up to 10 days after recovery. A single gram of feces from an infected dog may contain up to 10 billion viral particles; the infectious dose is as low as 1,000 particles. The virus can be carried on shoes, clothing, car tires, leashes, and any surface that has contacted infected feces.
Environmental Persistence
CPV-2 is exceptionally hardy in the environment. It survives freezing, heat up to 56 degrees Celsius (133 degrees Fahrenheit) for 30 minutes, most common disinfectants (quaternary ammonium compounds, alcohol, most detergents), ultraviolet light, and drying. At room temperature, the virus remains infectious in soil or on hard surfaces for 6 months to 1 year; in cold climates, it may persist for considerably longer. This environmental stability means that a yard, dog park, shelter kennel, or pet store where an infected dog has been can remain a source of infection for many months even without a currently infected dog present.
Who Is at Risk: Susceptibility Factors
| Risk Factor | Details |
|---|---|
| Age: 6 weeks to 6 months (unvaccinated) | Highest-risk age group; maternal antibodies waned, puppy vaccine series incomplete |
| Vaccination status | Unvaccinated or incompletely vaccinated dogs of any age; rarely, fully vaccinated adult dogs (vaccine failure) |
| Breed | Rottweiler, Doberman Pinscher, American Pit Bull Terrier, Labrador Retriever, German Shepherd reported to have higher susceptibility or more severe disease in multiple studies |
| Crowded housing | Animal shelters, puppy mills, pet stores; high viral load in environment and high-density dog contact |
| Prior illness or parasitism | Concurrent intestinal parasites (hookworms, roundworms, coccidia, Giardia) worsen outcomes; intestinal parasites must be treated concurrently |
| Poor nutrition or stress | Malnourished puppies have impaired immune function; stress from transport or rehoming suppresses immune response |
Symptoms of Parvo in Dogs
Incubation Period and Pre-Symptomatic Shedding
After exposure to CPV-2, the incubation period is 3 to 7 days (average 5 days) before the onset of clinical signs. During days 3 to 4 of incubation, the dog begins actively shedding virus in feces, before any symptoms are visible. This pre-symptomatic shedding period means infected dogs can expose others before their owners know anything is wrong.
Classical Parvo Presentation
Parvo produces a predictable sequence of deteriorating signs:
- Lethargy and loss of appetite (day 1 of illness): The first sign is usually a puppy that seems “off” or quiet and stops eating; often attributed to stress of a new home
- Vomiting (day 1 to 2): Initially may be bile or undigested food; progresses to frequent, persistent vomiting that depletes fluid rapidly
- Diarrhea, becoming bloody (day 2 to 3): Initially watery and yellow-brown, progressing to profuse and bloody (hematochezia or melena); often has a characteristic foul, distinctive odor that experienced veterinarians and shelter workers recognize immediately
- Dehydration and weakness (day 2 to 4): Fluid losses from vomiting and diarrhea rapidly cause dehydration; skin turgor decreases (skin “tents” when gently pulled), eyes become sunken, mucous membranes dry out
- Septic shock signs (day 3 to 5 without treatment): Pale or white gums, weak pulse, hypothermia (low body temperature, not fever), cardiovascular collapse; at this stage mortality is very high
SNAP Parvo Test
The IDEXX SNAP Parvo Test is a rapid antigen detection test performed at the veterinary clinic using a rectal swab. Results are available in 8 minutes. Sensitivity is approximately 92 percent and specificity approximately 99 percent for fecal antigen detection. A negative SNAP test in a dog with classic clinical signs does not definitively rule out parvo, particularly early in infection (before peak viral shedding) or in recently vaccinated puppies (the modified live vaccine can cause a transient positive result for 2 to 4 days post-vaccination). In negative-testing dogs with strong clinical suspicion, PCR testing of feces is a more sensitive confirmatory option.
Treatment of Parvovirus
Why There Is No Specific Antiviral
No antiviral drug has regulatory approval for the treatment of CPV-2 in dogs. Maropitant (Cerenia) and ondansetron address nausea and vomiting; antibiotics address secondary bacterial infection; IV fluids address dehydration. Research into CPV-specific antivirals is ongoing, and a monoclonal antibody (CPMA) has shown early promise in a small number of experimental studies, but as of 2025 it is not commercially available. The dog’s own immune system clears the virus, typically over 7 to 10 days; the goal of treatment is to keep the dog alive and functional during that window.
Inpatient (Hospitalized) Treatment: The Gold Standard
Hospitalized treatment provides the highest survival rates (85 to 95 percent) and is strongly recommended for all parvo cases. The standard protocol includes:
- Intravenous fluid therapy: Isotonic crystalloids (0.9 percent NaCl or Plasma-Lyte A/Normosol-R) to replace fluid losses from vomiting and diarrhea and maintain blood pressure; potassium supplementation to correct hypokalemia; glucose supplementation in hypoglycemic puppies (especially small breeds and very young puppies)
- Antiemetics: Maropitant (Cerenia) 1 mg/kg IV or SQ daily; ondansetron 0.1 to 0.2 mg/kg IV every 6 to 8 hours; both together in severe vomiting
- Antibiotics: Broad-spectrum to prevent and treat sepsis from bacterial translocation; most commonly ampicillin-sulbactam or amoxicillin-clavulanate combined with enrofloxacin or trimethoprim-sulfamethoxazole; metronidazole is added for anaerobic coverage
- Nutritional support: Early enteral nutrition (via nasoesophageal tube if the dog is not eating voluntarily) is now strongly preferred over old “gut rest” protocols; early nutrition supports intestinal crypt cell regeneration and improves outcomes significantly
- Oncotic support: In dogs with severe protein loss (hypoalbuminemia below 1.5 g/dL), colloids (hetastarch or fresh frozen plasma) or human serum albumin may be needed to maintain oncotic pressure
- Granulocyte colony-stimulating factor (G-CSF, filgrastim): Used by some internists to accelerate neutrophil recovery from bone marrow; evidence base is limited but the drug is low-risk
Outpatient (Home) Treatment: Limited Survival Rate
For owners who cannot afford hospitalization, outpatient protocols with subcutaneous fluids, injectable antiemetics, and oral antibiotics administered at home are used in some practices. Survival rates with outpatient protocols in carefully selected cases (mild to moderate disease, dogs still able to drink small amounts) range from 20 to 50 percent in published case series, compared to 85 to 95 percent with inpatient IV fluid therapy. Outpatient treatment is not recommended as a first choice; it is an option when the alternative is euthanasia due to financial constraints. Dogs on outpatient protocols should be rechecked daily and hospitalized immediately if they deteriorate.
Oseltamivir (Tamiflu): Evidence Does Not Support Routine Use
Oseltamivir (Tamiflu) was proposed as a potential parvo treatment because it inhibits neuraminidase, an enzyme used by some gut bacteria to promote intestinal colonization, which might reduce bacterial translocation. However, a randomized controlled trial (Savigny and Macintire, Journal of Veterinary Emergency and Critical Care, 2010) found no statistically significant benefit in survival rates or hospitalization duration when oseltamivir was added to standard supportive care. Current consensus statements from the American College of Veterinary Internal Medicine do not recommend oseltamivir for routine parvo treatment.
Vaccination: Prevention Is the Only Reliable Answer
The DA2PP (DHPP) Vaccine
The DA2PP or DHPP vaccine (Distemper, Adenovirus type 2, Parvovirus, Parainfluenza) is a combination modified live virus (MLV) vaccine considered a core vaccine for all dogs by every major veterinary organization. The CPV component generates an immune response that is highly protective against all currently circulating CPV-2 variants (CPV-2a, 2b, 2c).
| Age | Vaccination Recommendation | Notes |
|---|---|---|
| 6 to 8 weeks | First DA2PP dose | Maternal antibodies may interfere; some protection established |
| 10 to 12 weeks | Second DA2PP dose | 3 to 4 week interval from first dose required |
| 14 to 16 weeks | Third DA2PP dose (minimum 16 weeks old) | The final puppy dose must be given at or after 16 weeks of age; maternal antibodies virtually certain to have waned; this dose confers reliable immunity |
| 6 to 12 months later | Booster (“1-year booster”) | Given 6 to 12 months after the puppy series; confirms immunity |
| Adult dogs | Revaccination every 3 years | After the 1-year booster, studies show duration of immunity of at least 3 years and often longer; WSAVA recommends triennial vaccination for core vaccines in adults |
| Adult dog with unknown history | Two doses, 3 to 4 weeks apart | Then follow normal adult schedule |
Protecting Puppies Before Full Vaccination
Puppies are not fully protected until 2 weeks after the final dose of the puppy series (at or after 16 weeks). During this period, the risk of exposure must be managed carefully:
- Avoid areas with high dog traffic (dog parks, pet stores, grooming facilities) until 2 weeks after the final puppy dose
- Carry the puppy rather than walking it on sidewalks in areas where dog feces may be present
- Puppy socialization classes held in facilities that require proof of vaccination for all attendees are generally safe (the socialization benefit is significant; total isolation is not recommended)
- Visitors who have recently been in contact with unknown dogs should wash hands and ideally change shoes before handling the puppy
- Avoid any location where a parvo case has been reported in the past year
Isolation and Decontamination for Parvo-Positive Dogs
A dog confirmed positive for parvovirus must be strictly isolated from all other dogs for a minimum of 14 days after the last day of clinical signs, because viral shedding can continue for up to 10 days after clinical recovery. Parvo-positive dogs in a household should be kept in a room that other dogs cannot access, their waste should be double-bagged and disposed of, and caregivers should change shoes and wash hands with soap and water (not just hand sanitizer, which does not reliably inactivate parvovirus) before contacting other dogs. Clothing worn during care should be changed and laundered.
US Cost Overview for Parvo Treatment
| Service | Typical US Cost |
|---|---|
| Emergency exam | $100 to $200 |
| SNAP Parvo Test | $45 to $95 |
| Blood work (CBC, chemistry, electrolytes) | $150 to $400 |
| IV catheter placement and fluid therapy (per day) | $200 to $400 |
| Antiemetic injections (per day) | $60 to $150 |
| Antibiotic injections (per day) | $50 to $150 |
| Hospitalization fee (per day) | $150 to $500 |
| Total hospitalization, uncomplicated case (4 to 7 days) | $1,500 to $3,500 |
| Complicated case with septic shock, ICU | $3,500 to $8,000+ |
| Outpatient protocol (if offered) | $300 to $800 |
| DA2PP puppy vaccine (per dose) | $20 to $40 |
| Full puppy vaccine series (3 doses) | $60 to $120 |
Age-Specific Considerations
Puppies (6 Weeks to 6 Months)
- Peak risk group; the overwhelming majority of parvo cases occur in this age range
- Begin the DA2PP series at 6 to 8 weeks; do not delay the first dose, even knowing that maternal antibody may interfere; early doses provide partial protection in some puppies and trigger memory
- The final dose of the puppy series must be administered at or after 16 weeks of age; a 16-week dose alone (if the puppy missed earlier doses) followed by a booster 3 to 4 weeks later provides reliable protection
- Very small breed puppies (under 4 pounds) and very young puppies are at higher risk of hypoglycemia (low blood sugar) during parvo illness; this complication must be monitored and treated with IV or oral glucose supplementation
- Coccidia (Cystoisospora canis/ohioensis) and intestinal roundworms (Toxocara canis) frequently co-infect parvo puppies and worsen intestinal damage; fecal examination and appropriate deworming (fenbendazole for roundworms; trimethoprim-sulfamethoxazole or ponazuril for coccidia) are part of standard treatment
Adult Dogs (6 Months to 7 Years)
- Parvo in fully vaccinated adult dogs is rare; when it occurs, it typically represents vaccine failure, an incomplete vaccination history, or exposure to an exceptionally high viral load
- Unvaccinated adult dogs (rescued dogs with unknown histories, dogs from rural areas with no veterinary care) are fully susceptible and should receive a two-dose series 3 to 4 weeks apart upon intake
- Adult dogs that survive parvo illness typically develop strong, long-lasting immunity (years to lifelong); revaccination of a confirmed parvo survivor is still recommended per standard protocol but is primarily a safety measure
- Adult dogs in multi-dog households where a parvo case is confirmed should be checked for vaccination status; unvaccinated or incompletely vaccinated adult housemates are at high risk and should be isolated from the index case
Senior Dogs (8+ Years)
- Senior dogs with up-to-date vaccinations have excellent protection; clinical parvo in a well-vaccinated senior is extremely rare
- Senior dogs with lapsed vaccination (3 or more years since last booster) from shelters or with unknown histories should be revaccinated; a single dose is usually sufficient to anamnostically boost immunity in a dog with a prior vaccination history
- If a senior dog develops parvo (typically a rescue with unknown history), prognosis is more guarded than in a young adult because senior dogs may have concurrent conditions (renal insufficiency, cardiac disease) that complicate fluid therapy management; careful fluid rate monitoring and oncotic support are more important
- Immunosenescence (age-related immune decline) may reduce vaccine efficacy in very old dogs; titers can be measured to verify protective antibody levels if there is clinical concern, though this is rarely needed in practice
Myths and Facts About Parvo
My puppy never leaves the yard, so it cannot get parvo.
Parvovirus is carried into yards on shoes, clothing, car tires, and any object that has contacted contaminated soil or feces. Wild animals including raccoons, coyotes, and foxes can carry and shed CPV-2 variants in feces. A puppy in a fenced yard that its owner walked through after visiting a dog park, pet store, or sidewalk is not isolated from exposure. The virus survives in soil for 6 to 12 months; a yard where an infected dog was present years earlier may still harbor infectious virus. Vaccination, not isolation, is the only reliable protection.
If my puppy got all its shots, it cannot get parvo.
A puppy is not fully protected until 2 weeks after the final dose of the puppy series, which must be given at or after 16 weeks of age. A puppy that received two doses but not the critical third dose at 16 weeks (or received its last dose at 12 weeks and was not brought back for the 16-week dose) may have incomplete protection depending on when maternal antibodies waned. Stopping the series early because “the puppy got most of its shots” is one of the most common preventable causes of parvo in vaccinated puppies. The full series through 16 weeks must be completed.
Parvo only kills puppies; adult dogs always recover.
While puppies are at highest risk for severe disease and death, unvaccinated adult dogs of any age can develop life-threatening parvo. In shelter populations with poor vaccination coverage, parvo outbreaks affect dogs of all ages. Certain breeds (Rottweiler, Doberman Pinscher) appear to have a genetic predisposition to more severe illness. An unvaccinated adult dog exposed to parvovirus requires the same emergency treatment as a puppy and faces the same near-100 percent fatality rate without treatment.
Red Flags: Signs That Mean Go to the Vet Right Now
- Bloody diarrhea in an unvaccinated or incompletely vaccinated puppy of any age
- Repeated vomiting combined with complete refusal to eat or drink in a puppy under 6 months
- Sudden profound lethargy in a puppy, especially one recently acquired from a shelter, pet store, or rehomed from another family
- Pale, white, grey, or bluish gums in a puppy with vomiting and diarrhea (sign of septic shock)
- Puppy that feels cold to the touch, especially the ears and paws (hypothermia from septic shock)
- A puppy that collapses or cannot stand
- Any combination of the above in a puppy that has not received the complete vaccination series through 16 weeks of age
Frequently Asked Questions About Parvo
How long does parvo live in my yard or home?
Parvovirus survives in soil outdoors for 6 months to 1 year at typical temperatures; in cold climates or protected soil (under leaf litter, beneath decking), it may persist considerably longer. Indoors on hard, non-porous surfaces, it survives weeks to months. On soft surfaces (carpet, upholstery, fabric), it can survive for several months but is harder to test. The practical implication: a yard or home where a parvo-positive dog has been should be considered potentially contaminated for at least a year. Diluted bleach (1:30 ratio) inactivates the virus on hard surfaces; soil and soft surfaces cannot be reliably decontaminated and should be considered a risk for unvaccinated dogs for the duration.
Can my vaccinated dog get parvo from a dog that is infected?
In a fully vaccinated dog that has completed its series and received appropriate boosters, parvo is very rare. The modified live DA2PP vaccine induces high neutralizing antibody titers and long-lasting memory immune responses. Vaccine failures do occur but are uncommon; they are most often seen in dogs with a history of maternal antibody interference during the puppy series (resulting in a gap in protection), in dogs with immune deficiency, or in dogs whose last booster was many years prior. A fully up-to-date adult dog should not be considered at significant risk from casual exposure to a parvo-positive dog, though keeping the infected dog isolated is still correct practice.
How long should I wait before getting a new puppy after a parvo death in my home?
After a parvo-related death or diagnosis, the official recommendation from most veterinary infectious disease specialists is to wait a minimum of 6 months before introducing a new puppy; some recommend 12 months given the virus’s environmental persistence. Any new puppy introduced to the premises should be fully vaccinated with the final dose administered at or after 16 weeks and fully protected (2 weeks post-final dose) before being allowed to contact previously contaminated areas. Decontamination of hard surfaces with diluted bleach reduces but does not eliminate risk. Soil in outdoor areas should be considered contaminated; some owners use sod replacement or paving in high-traffic areas to reduce risk.
My puppy tested positive but seems fine. Should I still hospitalize?
Yes, if at all possible. Parvo can deteriorate very rapidly; a puppy that appears relatively bright and alert at the time of a positive SNAP test may be in the early or pre-severe phase of illness. Studies comparing matched cohorts show that puppies hospitalized early (before severe dehydration and neutropenia develop) have significantly higher survival rates and shorter hospital stays than those admitted after deterioration. The SNAP test becomes positive before peak illness; a positive test in a “not that sick” puppy is an indication for immediate hospitalization, not a reason to watch and wait. If absolute financial constraints prevent hospitalization, discuss outpatient protocols with your veterinarian and set clear criteria for emergency hospitalization if the puppy declines.
Can cats or people catch parvo from a dog?
CPV-2 does not infect humans; parvovirus is not a zoonosis and cannot be transmitted from dogs to people. CPV-2 can infect cats: a variant of CPV-2 (primarily CPV-2b and 2c) can replicate in cats and has been isolated from cats with clinical enteritis, though feline panleukopenia virus (FPV) remains the primary parvovirus threat for cats. The feline panleukopenia vaccine cross-protects against CPV-2 variants in cats. If a CPV-positive dog shares a household with an unvaccinated or incompletely vaccinated cat, veterinary advice should be sought. Humans cannot be infected but can carry the virus mechanically on clothing and hands, so standard hygiene after contact with a parvo-positive dog is important to prevent spread to other dogs.
Is it safe to take my puppy to puppy classes before finishing the vaccine series?
The American Veterinary Society of Animal Behavior (AVSAB) recommends that the socialization benefit of early puppy classes outweighs the parvo risk in settings with appropriate biosafety measures. Classes are considered acceptable starting 7 days after the first DA2PP dose, provided the facility requires proof of current vaccination for all attending puppies and the floor is cleaned with an effective disinfectant between classes. Avoiding classes entirely until 16 weeks means the socialization window (8 to 14 weeks) passes, which contributes to behavioral problems including fear and aggression that affect quality of life for years. Choose a class with strict health requirements and avoid facilities that do not require vaccination records.
What is the survival rate for parvo with treatment vs. without treatment?
With aggressive inpatient IV fluid therapy and supportive care: approximately 85 to 95 percent of hospitalized parvo dogs survive, based on multiple case series. Without any treatment: approximately 5 to 10 percent survive, as the virus alone is typically not fatal but the dehydration, sepsis, and electrolyte disturbances it causes are. With outpatient oral supportive care at home: approximately 20 to 50 percent survival in selected mild-to-moderate cases, depending on the severity at presentation and the owner’s ability to administer care. The difference between inpatient and no-treatment survival illustrates why treatment decisions, while difficult given the cost of hospitalization, have a major biological impact on outcome.
For more guides on keeping your dog healthy, browse all our Dog Health articles.
Explore Dog Health Articles